Indiclor and Octreotide Long-Acting Injection

In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.

Using octreotide together with indium pentetreotide In-111 can alter the effects of indium pentetreotide In-111. Contact your doctor when to start and stop therapy with octreotide so it does not interfere with indium pentetreotide In-111. You may need a dose adjustment or special test to safely use both medications. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

ADJUST DOSING INTERVAL: Somatostatin analogs may reduce the accumulation of indium In-111 pentetreotide radioactivity in tumors. The sensitivity of the scintigraphy may be reduced.

MANAGEMENT: Consideration should be given to temporarily suspending somatostatin analog therapy prior to the administration of indium In-111 pentetreotide. Patients should be monitored for any signs of withdrawal.

Indiclor

Generic Name: indium pentetreotide in-111

Brand name: OctreoScan

Synonyms: Indium In-111 Pentetreotide

What is Indiclor?

Octreotide Long-Acting Injection

Generic Name: octreotide

Brand name: Sandostatin, Sandostatin LAR Depot

Synonyms: Octreotide (injection), Octreotide

What is Octreotide Long-Acting Injection?